Vinpai FCF per Share
The Free Cash Flow per Share of Vinpai (ALVIN.PA) as of Oct 27, 2026 is -0.09 EUR.
Get this data via API
Financial Data API
FCF per Share
-0.09EUR
YoY
57,906.94%
Last updated:
Free Cash Flow per Share of Vinpai is 2025 -0.09 EUR. Free Cash Flow per Share of Vinpai was 2024 -0.00 EUR. It decreases by 57,906.94% lower compared to the previous year.
The Vinpai FCF per Share history
3 Years
10 Years
25 Years
Max
FCF per Share
Date
FCF per Share
Jan 1, 2021
-0.46 EUR
Jan 1, 2022
-0.00 EUR
Jan 1, 2023
-0.00 EUR
Jan 1, 2025
-0.09 EUR
| YEAR | FCF per Share | YoY |
|---|---|---|
| -0.09EUR | +57,906.94% | |
| -0.00EUR | +70.40% | |
| -0.00EUR | -99.98% | |
| -0.46EUR | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Vinpai Stock analysis
What does Vinpai do? Vinpai SA generates revenue through the design, manufacture, and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries. The company offers standard and tailor-made products including alternative cheeses, dressing sauces, dairy alternative products, biscuits, cakes, and flavours across its four business segments: food industry, cosmetics, food supplementation, and medical device. VINPAI Cosmetics develops algae-mineral solutions for peel-off masks, actives, and ingredients ranges, as well as medical device solutions from dental to patch and moulding. The company serves customers in more than 40 countries worldwide, with its products primarily targeting food manufacturers, cosmetics brands, and medical device companies seeking sustainable, plant-based alternatives.
Vinpai SA's product portfolio includes alternative cheeses, dressing sauces, dairy alternatives, biscuits, cakes, and flavours for the food industry segment. For cosmetics, the company provides algae-mineral solutions for peel-off masks, actives, and ingredients. The medical device segment focuses on dental, patch, and moulding solutions. Food supplementation involves plant-based functional ingredients tailored for dietary needs. The company's global presence in over 40 countries supports its sales to food manufacturers, cosmetics brands, and medical device companies.
The company's revenue streams are derived from the sale of its standard and custom products to food manufacturers, cosmetics brands, and medical device companies. VINPAI Cosmetics' algae-mineral solutions for peel-off masks and actives are sold to cosmetics brands, while medical device solutions for dental, patch, and moulding applications are sold to medical device companies. Food supplementation ingredients target dietary supplement manufacturers, and dairy alternatives and plant-based flavours are sold to food producers across multiple industries. Vinpai is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Vinpai stock
Free Cash Flow per Share of Vinpai is -0.09 EUR in 2025.
On Eulerpool you can find the complete historical development of Free Cash Flow per Share Vinpai since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cash Flow — Vinpai
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — Vinpai
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth